HeartFlow, Inc. (HTFL)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Non-invasive Coronary Artery Disease Detection Solutions	125.81M
Non-invasive Coronary Artery Disease Detection Solutions Growth	44.32%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	115.04M
United States Growth	48.00%
United Kingdom	5.19M
United Kingdom Growth	15.43%
Japan	4.30M
Japan Growth	7.34%
Rest of Europe	1.29M
Rest of Europe Growth	35.22%